Hollings researchers study SARS-CoV-2 antibodies in asymptomatic & symptomatic individuals

(Medical University of South Carolina) MUSC Hollings Cancer Center researchers screened more than 60,000 blood samples from symptomless individuals in the Southeastern U.S., finding that approximately 3% of the population is asymptomatic. These individuals had stronger antibody responses to COVID-19 versus symptomatic patients.